POLR2A and cancer: Trio‐based clinical exome sequencing, performed on genomic DNA obtained from leukocytes (Twist Bioscience, South San Francisco, CA), did not reveal any cancer‐associated pathogenic variant, but revealed a novel de novo POLR2A missense variant, c.3865G > A (p.Glu1289Lys).